文献速递肺栓塞与肺血管病

炎症与肥胖在肺动脉高压中相关但与不同结局相关

Inflammation and Obesity Correlate in Pulmonary Hypertension but Are Associated with Diverging Outcomes.
PubMed 文献 · Am J Respir Crit Care Med · 2026-01-01

本研究采用纵向C反应蛋白(CRP)浓度的时间序列聚类,并在三个英国/国际独立队列(n=10,301)中验证聚类间临床差异。患者被分为两个稳定的CRP聚类(中位CRP 2 vs 6.5 mg/L),高CRP聚类者体重指数(BMI)更高、右心房压更高、6分钟步行距离更短;CRP与更差生存相关,而较高BMI反而与更好生存和更低肺血管阻力相关。

要点

  • CRP可区分肺动脉高压的两种临床内型,高CRP聚类者BMI更高、右心房压更高、6分钟步行距离更短。
  • 炎症(CRP)与更差生存、更多合并症、更高肺血管阻力和吸烟状态相关。
  • 较高BMI与更好生存和更低肺血管阻力相关,且不负面影响6分钟步行距离的治疗相关功能反应。

核心结论

  • CRP与BMI在全因肺动脉高压中存在关联,但两者与不同临床结局相关,炎症和肥胖是临床试验设计应考虑的表型。

研究设计与样本

  • 纵向CRP浓度时间序列聚类研究,并在三个英国/国际独立队列(n=10,301;英国队列、ASPIRE和FDA队列)中以临床截断值验证。
  • 采用线性回归和Cox回归模型分析CRP与功能和死亡结局的关联,涵盖所有肺动脉高压病因(1-5组)。
  • 对既往已发表阵列进行多组学分析以增加机制性认识。

主要发现

  • 患者被分为两个稳定的CRP聚类(中位CRP 2 vs 6.5 mg/L)。
  • 高CRP聚类者BMI更高(中位数差5.4 kg/m2)、右心房压更高(中位数差2 mm Hg)、6分钟步行距离更短(中位数差55 m)。
  • 炎症与更差生存和合并症、更高肺血管阻力及吸烟状态相关。
  • 蛋白组学和转录组学分析显示CRP与BMI关联不同的炎症谱。
  • 尽管与CRP相关,较高BMI与更好生存和更低肺血管阻力相关,且不负面影响6分钟步行距离治疗相关功能反应。

关键数值与推荐

  • 中位CRP两个聚类为2 vs 6.5 mg/L。
  • 高CRP聚类BMI中位数差5.4 kg/m2、右心房压中位数差2 mm Hg、6分钟步行距离中位数差55 m。
  • 验证队列样本量n=10,301(英国队列、ASPIRE和FDA队列)。

临床怎么用

  • 在肺动脉高压评估中可考虑CRP用于临床内型分型,并关注炎症与肥胖表型对结局的不同影响。
  • 临床试验设计时应考虑炎症和肥胖表型。

局限性

  • 原文摘要未报告具体局限性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE AND OBJECTIVES: Inflammation is associated with all types of pulmonary hypertension (PH), both as a known cause and as a putative confounder. The most common marker of inflammation, C-reactive protein (CRP), has not been widely studied in PH. This study set out to clarify if CRP informs clinical endotyping and outcomes. METHODS: Time-series clustering of longitudinal CRP concentrations was employed. Clinical differences between clusters were validated in three independent U.K./international cohorts using clinical cutoff values (n = 10,301; U.K. cohort, ASPIRE and FDA cohort). Associations were analyzed with functional and mortality outcomes by linear and Cox regression models including all causes of PH (groups 1-5). To add mechanistic insight, multiomics were interrogated from associated previously published arrays. MEASUREMENTS AND MAIN RESULTS: Patients were segregated into two stable CRP clusters (median CRP, 2 vs. 6.5 mg/L), with the high cluster exhibiting significantly higher body mass index (BMI) (difference between medians [DBM], 5.4 kg/m2), higher right atrial pressure (DBM, 2 mm Hg), and reduced 6-minute-walk distance (DBM, 55 m). Inflammation was associated with worse survival and comorbidities, higher pulmonary vascular resistance, and smoking status. CRP and BMI were associated with differing inflammatory profiles in proteomic and transcriptomic analyses. Despite the relationship with CRP, higher BMI was associated with improved survival and lower pulmonary vascular resistance and did not negatively affect 6-minute-walk distance treatment-related functional responses. CONCLUSIONS: We establish a relationship between CRP and BMI across all-cause PH, although CRP and BMI are associated with diverging clinical outcomes. Inflammation and obesity are relevant phenotypes for consideration in clinical trial design. Understanding their impacts on outcomes is important for clinical practice.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. De Bie E, Correa-Jaque P, Jones R, et al. Inflammation and Obesity Correlate in Pulmonary Hypertension but Are Associated with Diverging Outcomes. Am J Respir Crit Care Med. 2026. PMID: 40788756. doi:10.1164/rccm.202412-2393OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。